Sterile Compounding Pharmacies Global Market Report 2024

Description

Sterile compounding pharmacies are specialized facilities that prepare personalized medications in a sterile environment, tailoring medication to the specific needs of individuals. This approach proves beneficial for various reasons, including patient intolerance to standard commercial doses or specific components. Compounding in a sterile environment enables patients to receive drugs with customized doses and formulations, excluding non-essential and undesirable components.

The primary products in sterile compounding pharmacies include injectables, nasal, ocular, and otic formulations. Injectables are pharmacological substances or drugs intended for injection into the body using a needle and syringe. Sterile compounding pharmacies offer production services such as customization, patient-specific dosing, and elimination of intolerable components, ensuring the safety, sterility, and quality of injectable medications tailored to individual patient requirements. These injectables find application in various therapeutic areas, including hormone replacement therapy, pain management, dermatology, oncology, hematology, dental, among others. Administration routes include intravenous, intramuscular, and subcutaneous, catering to diverse end-users such as adults, pediatrics, geriatrics, and veterinary applications.

The sterile compounding pharmacies market research report is one of a series of new reports from The Business Research Company that provides sterile compounding pharmacies market statistics, including sterile compounding pharmacies industry global market size, regional shares, competitors with a sterile compounding pharmacies market share, detailed sterile compounding pharmacies market segments, market trends and opportunities, and any further data you may need to thrive in the sterile compounding pharmacies industry. This sterile compounding pharmacies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sterile compounding pharmacies market size has grown strongly in recent years. It will grow from $4.99 billion in 2023 to $5.3 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%. The growth observed during the historical period can be attributed to factors such as concerns about patient safety, a shift towards personalized medicine, the increasing adoption of home infusion therapies, the involvement of sterile compounding pharmacies in clinical trials and investigational drugs, and the support for rare diseases.

The sterile compounding pharmacies market size is expected to see strong growth in the next few years. It will grow to $6.7 billion in 2028 at a compound annual growth rate (CAGR) of 6.0%. The anticipated growth in the forecast period can be attributed to factors such as the rise in chronic diseases, the aging population and increasing healthcare needs, concerns about drug shortages and supply chain disruptions, advancements in precision medicine, and an increased focus on patient-centric care. Major trends expected in the forecast period include the integration of automation and robotics, a focus on stringent regulatory compliance, the emphasis on personalized medicine and specialized compounds, a shift towards outsourced compounding services, and technological advances in aseptic techniques.

The anticipated surge in the demand for personalized medicine is poised to propel the growth of the sterile compounding pharmacies market in the future. Personalized medicine, which utilizes information about an individual's genes or proteins to prevent, diagnose, or treat diseases, is facilitated by sterile compounding pharmacies. These pharmacies play a crucial role in delivering personalized medications in a sterile environment, tailoring drugs based on individual needs to enhance treatment outcomes, patient satisfaction, and therapy adherence. Notably, the approval of 12 new personalized medicines in 2022, as reported by the Personalized Medicine Coalition, underscores the increasing prominence of personalized medicine. Hence, the escalating demand for personalized medicine is a driving force behind the growth of the sterile compounding pharmacies market.

The burgeoning aging population significantly contributes to the growth of the sterile compounding pharmacies market. An aging population, characterized by an increasing proportion of older individuals within a society, benefits from sterile compounding pharmacies that provide customized medication solutions. These pharmacies prepare medications in various forms, such as liquid, topical, or suppository, making them more accessible for the aging population. According to October 2022 data from the World Health Organization, the global population aged 60 or above is expected to grow from 1 billion in 2020 to 1.4 billion in 2030. Thus, the expanding aging population is a driving factor for the growth of the sterile compounding pharmacies market.

The adoption of robotic automation emerges as a prominent trend in the sterile compounding pharmacies market. Major companies in the market focus on leveraging robotic automation to enhance their market position. For example, in March 2023, Omnicell Inc., a healthcare technology company, introduced the IVX Station, a robotic compounding technology designed for safe and efficient sterile compounding preparations using automation. This technology features an automated compounding process in an ISO Class 5 environment, incorporating continuous monitoring of temperature, humidity, and particles. The IVX Station prioritizes safety with advanced vision systems, gravimetric verification, auto-labeling, and automated application of tamper-evident syringe caps. Moreover, it offers scalability through a cloud-based formulation library, ensuring access to the latest authorized formulations for manufacturers.

Major companies in the sterile compounding pharmacies market adopt strategic acquisition and collaboration as part of their growth strategy. A strategic acquisition involves one company purchasing another or its assets to achieve long-term strategic objectives. In October 2023, Sharp, a pharmaceutical packaging company, acquired Berkshire Sterile Manufacturing (BSM) to enhance its capabilities in offering fully integrated small-to-medium scale sterile injectable services. The acquisition complements Sharp's services with BSM's expertise in sterile manufacturing and Contract Development and Manufacturing Organization (CDMO) services.

In January 2022, Revelation Pharma Corp, a compounding pharmacy company, acquired Innovation Compounding Inc. for an undisclosed amount. This strategic acquisition aligns with Revelation's goal of establishing a national network of 503A and 503B compounding pharmacies. Innovation Compounding Inc., a 503A compounding pharmacy, provides sterile and non-sterile compounded pharmaceuticals to patients in 49 states.

Major companies operating in the sterile compounding pharmacies market report are B. Braun SE, PharMerica Corporation, Fagron Group BV, QuVa Pharma Inc., NewCo Pharma GmbH, Medisca, PharMEDium Healthcare Holdings Inc., Central Admixture Pharmacy Services (CAPS), SandsRx LLC, LeeSar Inc., Avella Specialty Pharmacy, Stokes Pharmacy Inc., Imprimis Pharmaceuticals Inc., Wells Pharmacy Network LLC, McGuff Compounding Pharmacy Services Inc., Potter's House Apothecary Inc., Pharos Innovations LLC, Triangle Compounding Pharmacy Inc., Valor Compounding Pharmacy Inc., Pace Pharmacy, PenCol Specialty Pharmacy LLC, Pavilion Compounding Pharmacy LLC, Olympia Pharmacy, MedisourceRx, Stat RX Pharmacy, Rx3 Compounding Pharmacy, Atlas Pharmaceuticals Co. Ltd., ReNue Rx, Premier Pharmacy Labs Inc., Absolute Pharmacy Inc.

North America was the dominant region in the sterile compounding pharmacies market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sterile compounding pharmacies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the sterile compounding pharmacies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sterile compounding pharmacies market consists of sales of injectable drugs and infusions created in an environment free from microorganisms. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sterile Compounding Pharmacies Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sterile compounding pharmacies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sterile compounding pharmacies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sterile compounding pharmacies market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Product: Injectables; Nasal; Ocular; Otic
2) By Therapeutic Area: Hormone Replacement Therapy; Pain Management; Dermatology; Oncology; Hematology; Dental; Other Therapeutic Areas
3) By Route of Administrations: Intravenous; Intramuscular; Subcutaneous
4) By End-Users: Adults; Pediatrics; Geriatrics; Veterinary
Companies Mentioned: B. Braun SE; PharMerica Corporation; Fagron Group BV; QuVa Pharma Inc.; NewCo Pharma GmbH
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r13874

1. Executive Summary

2. Sterile Compounding Pharmacies Market Characteristics

3. Sterile Compounding Pharmacies Market Trends And Strategies

4. Sterile Compounding Pharmacies Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Sterile Compounding Pharmacies Market Size and Growth

5.1. Global Sterile Compounding Pharmacies Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Sterile Compounding Pharmacies Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Sterile Compounding Pharmacies Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Sterile Compounding Pharmacies Market Segmentation

6.1. Global Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Injectables
Nasal
Ocular
Otic
6.2. Global Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hormone Replacement Therapy
Pain Management
Dermatology
Oncology
Hematology
Dental
Other Therapeutic Areas
6.3. Global Sterile Compounding Pharmacies Market, Segmentation By Route of Administrations, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Intravenous
Intramuscular
Subcutaneous
6.4. Global Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Adults
Pediatrics
Geriatrics
Veterinary

7. Sterile Compounding Pharmacies Market Regional And Country Analysis

7.1. Global Sterile Compounding Pharmacies Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Sterile Compounding Pharmacies Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Sterile Compounding Pharmacies Market

8.1. Asia-Pacific Sterile Compounding Pharmacies Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Sterile Compounding Pharmacies Market

9.1. China Sterile Compounding Pharmacies Market Overview
9.2. China Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Sterile Compounding Pharmacies Market

10.1. India Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Sterile Compounding Pharmacies Market

11.1. Japan Sterile Compounding Pharmacies Market Overview
11.2. Japan Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Sterile Compounding Pharmacies Market

12.1. Australia Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Sterile Compounding Pharmacies Market

13.1. Indonesia Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Sterile Compounding Pharmacies Market

14.1. South Korea Sterile Compounding Pharmacies Market Overview
14.2. South Korea Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Sterile Compounding Pharmacies Market

15.1. Western Europe Sterile Compounding Pharmacies Market Overview
15.2. Western Europe Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Sterile Compounding Pharmacies Market

16.1. UK Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Sterile Compounding Pharmacies Market

17.1. Germany Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Sterile Compounding Pharmacies Market

18.1. France Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Sterile Compounding Pharmacies Market

19.1. Italy Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Sterile Compounding Pharmacies Market

20.1. Spain Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Sterile Compounding Pharmacies Market

21.1. Eastern Europe Sterile Compounding Pharmacies Market Overview
21.2. Eastern Europe Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Sterile Compounding Pharmacies Market

22.1. Russia Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Sterile Compounding Pharmacies Market

23.1. North America Sterile Compounding Pharmacies Market Overview
23.2. North America Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Sterile Compounding Pharmacies Market

24.1. USA Sterile Compounding Pharmacies Market Overview
24.2. USA Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Sterile Compounding Pharmacies Market

25.1. Canada Sterile Compounding Pharmacies Market Overview
25.2. Canada Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Sterile Compounding Pharmacies Market

26.1. South America Sterile Compounding Pharmacies Market Overview
26.2. South America Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Sterile Compounding Pharmacies Market

27.1. Brazil Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Sterile Compounding Pharmacies Market

28.1. Middle East Sterile Compounding Pharmacies Market Overview
28.2. Middle East Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Sterile Compounding Pharmacies Market

29.1. Africa Sterile Compounding Pharmacies Market Overview
29.2. Africa Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Sterile Compounding Pharmacies Market Competitive Landscape And Company Profiles

30.1. Sterile Compounding Pharmacies Market Competitive Landscape
30.2. Sterile Compounding Pharmacies Market Company Profiles
- 30.2.1. B. Braun SE
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. PharMerica Corporation
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Fagron Group BV
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. QuVa Pharma Inc.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. NewCo Pharma GmbH
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Sterile Compounding Pharmacies Market Other Major And Innovative Companies

31.1. Medisca
31.2. PharMEDium Healthcare Holdings Inc.
31.3. Central Admixture Pharmacy Services (CAPS)
31.4. SandsRx LLC
31.5. LeeSar Inc.
31.6. Avella Specialty Pharmacy
31.7. Stokes Pharmacy Inc.
31.8. Imprimis Pharmaceuticals Inc.
31.9. Wells Pharmacy Network LLC
31.10. McGuff Compounding Pharmacy Services Inc.
31.11. Potter's House Apothecary Inc.
31.12. Pharos Innovations LLC
31.13. Triangle Compounding Pharmacy Inc.
31.14. Valor Compounding Pharmacy Inc.
31.15. Pace Pharmacy

32. Global Sterile Compounding Pharmacies Market Competitive Benchmarking

33. Global Sterile Compounding Pharmacies Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Sterile Compounding Pharmacies Market

35. Sterile Compounding Pharmacies Market Future Outlook and Potential Analysis

35.1 Sterile Compounding Pharmacies Market In 2028 - Countries Offering Most New Opportunities
35.2 Sterile Compounding Pharmacies Market In 2028 - Segments Offering Most New Opportunities
35.3 Sterile Compounding Pharmacies Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer